Literature DB >> 1338074

Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise?

P Hjemdahl, I K Wiklund.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1338074     DOI: 10.1097/00004872-199210120-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  9 in total

Review 1.  Quality of life with nonpharmacologic treatment of hypertension.

Authors:  J P Roel; C L Hildebrant; R H Grimm
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

2.  Validity and reliability of the Spanish version of the Psychological General Well-Being Index.

Authors:  X Badia; F Gutiérrez; I Wiklund; J Alonso
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

Review 3.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

4.  Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.

Authors:  I Wiklund; F Waagstein; K Swedberg; A Hjalmarsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

5.  Psychometric properties of the VSQLQ in black patients with mild hypertension. Vital Signs Quality of Life Questionnaire.

Authors:  N K Leidy; J K Schmier; A E Bonomi; M Legro; T Zyczynski; B W Kong
Journal:  J Natl Med Assoc       Date:  2000-12       Impact factor: 1.798

Review 6.  Hypertension and current issues in compliance and patient outcomes.

Authors:  T M Zyczynski; K S Coyne
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

7.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors:  P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal:  BMJ       Date:  1993-04-10

Review 8.  Epidemiology of stroke. Importance of preventive pharmacological strategies in elderly patients and associated costs.

Authors:  I Kawachi
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

Review 9.  Individualised selection of antihypertensive therapy.

Authors:  L H Opie
Journal:  Drugs       Date:  1993       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.